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The precision by which animal diseases are diagnosed affects our ability to make
informed decisions with regards to animal health management, from a clinical and
economic perspective. Lameness is a major health condition in dairy cattle. The
underlying causes of lameness include bovine digital dermatitis (BDD), which is reported
as one of the main causes of infectious lameness in dairy cattle. Presently, the gold
standard for BDD diagnosis in dairy cattle is visual inspection of lifted hooves—a labour
intensive and subjective method. Research has suggested that Treponema spp. are the
main pathogens associated with the establishment of BDD. We explored the potential
of indirect enzyme-linked immunosorbent assay (ELISA) as a diagnostic serological
tool in the identification of cows at different stages of BDD. Additionally, we evaluated
the predictive power of this diagnostic tool on the future occurrence of BDD lesions.
A total of 232 cows from three farms were used in the study. Serum samples and
hoof health data were collected at three time points: ∼ 30 days pre-calving, around
calving, and approximately 30 days post-calving. The mean absorbance from the
ELISA test was compared across different clinical presentations of BDD as assessed
by visual inspection of the hooves according to the M-stage classification system.
A transition model was developed to estimate the probability of lesion occurrence in
time t + 1 based on the spectrophotometer (absorbance) reading in time t. The mean
absorbance reading for both IgG1 and IgG2 anti-Treponema antibodies was associated
with disease presence—apart from M4.1 lesions, animals with no lesions had a lower
mean when compared to animals with lesions regardless of the score. Additionally, the
mean absorbance reading of animals with active lesions was higher when compared to
animals with no lesions. However, the anti-Treponema antibody assays failed to identify
disease presence in a consistent manner. Moreover, indirect ELISA readings were not
a predictor of the future occurrence of BDD lesions. In conclusion, although the levels
anti-Treponema antibodies were associated with disease presence, the ELISA test failed
to detect disease unequivocally and had no predictive value in the future occurrence of
BDD lesions.
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INTRODUCTION
Lameness is the second most important health condition in dairy
cattle in the UK in terms of production losses and the most
important welfare issue (1). Lameness is a symptom rather than
a disease which can have different aetiologies, from infectious to
non-infectious causes (2).
Bovine digital dermatitis (BDD) is a leading cause of infectious
lameness in British dairy cattle, causing ulcerative skin lesions,
with significant impact on animal production and welfare. The
impact of BDD is associated with the stage of the disease. Acute
ulcerative phases are more likely to result in a change in the
behaviour of the cow due to pain, leading to a reduction in
milk yield and fertility. Animals chronically affected by digital
dermatitis can perpetuate the disease in the herd, acting as
pathogen reservoirs and contributing to the establishment of an
endemic nature of the ailment, which can result in premature
culling of animals and added costs to control and eradicate
the disease (3, 4). Identifying the stage of the disease is thus
important to inform the treatment and control strategy (5) and to
allow for the proper estimation of the economic impact of BDD.
Different methods are currently used to capture data related
to BDD. Herd mobility scoring is a screening tool widely used
to identify animals afflicted by lameness, followed by clinical
investigation of the underlying cause and treatment. Yet mobility
scoring is subjective and prone to intra- and inter-observer
bias (2, 6). Additionally, the presence of BDD lesion(s) is
not always associated with lameness, which could lead to the
underreporting of the problem (7). The reference for detecting
and classifying BDD is the clinical observation of lifted hooves
in a foot trimming chute. In addition to being labour-intensive
and expensive, this unavoidable routine, meant for adequate
cleaning and examination to be carried, causes stress to the
animal (8, 9). Additionally, some cases with less obvious lesions
can be overlooked (10). As such, researchers have suggested
alternative approaches for monitoring BDD, including visual
inspection during milking routine at the parlour (8, 9), and
investigated the use of infrared thermography to identify animals
with lesions (11). Unfortunately, these tend to have a lower
diagnostic capacity when compared to the reference (12).
Research has suggested that Treponema species are a key
pathogen triggering the pathogenic cascade that leads to the
establishment of the disease (13–15). The immunologic response
to the presence of these pathogens can be assessed through
serology which could stand as a more objective and practical
alternative tool of identifying animals with BDD when compared
to the current reference diagnostic method (16). A study by
Frössling et al., (17) found that the presence of serum anti-
Treponema antibodies assessed through indirect ELISA could be
used with high sensitivity and specificity for the identification of
BDD presence at animal and herd levels. Additionally, the results
from serology with milk samples from the bulk tank showed
good agreement with those from individual cows, suggesting a
potential use as a screening tool at herd level (17). The usefulness
of indirect enzyme-linked immunosorbent assay (ELISA) as
a diagnostic tool in identifying BDD clinical stages has been
previously assessed in dairy heifers through the measurement of
anti-Treponema antibodies. The study found that the mean anti-
Treponema antibody titres for animals experiencing a DD lesion
for the first time increased by 56% when compared to results
before the onset of the disease. Additionally, animals treated with
oxytetracycline for a DD acute lesion had their anti-Treponema
antibodies titres decreased to levels closer to those of animals
without DD lesions after an average of 223 days (18).
The main aim of this paper was to assess whether indirect
ELISA is suitable for the diagnosis and severity assessment of
bovine digital dermatitis. It also explored the value of the test
as a predicting tool of the future occurrence of BDD lesion by
hypothesizing a time lag between the exposure to Treponema spp.
and the development of clinical signs of disease. Finally, we made
use of the available data to explore risk factors for the occurrence
of BDD.
MATERIALS AND METHODS
Ethical approval for the study was granted by the University
of Liverpool Research Ethics Committee (reference VREC466).
ASPA regulated procedures were conducted under a HomeOffice
Project License (Reference Number: PPL 70/8330).
Farm Characteristics and Animals
A cohort of dairy cattle from three commercial dairy farms in
the North West of England and North Wales were followed
from September 2016 to August 2017. Farms were conveniently
recruited for their proximity to the research institute and for their
willingness to take part in the study. The farms’ characteristics are
described in more detail in a previous study (19).
On farm 1, animals were housed in concrete cubicles with
different mattress types and bedded with sawdust. Automatic
scrapers removed manure from pen passageways two or three
times per hour. The milking parlour and part of the collecting
yard had rubber floor matting. Dry cows were housed in grooved
concrete floors with deep straw bedding. Youngstock spent
summer on pasture and winter housed in cubicle sheds.
Cows were housed in cubicles on farm 2. High yielding cows
were kept in sheds with concrete cubicles with mats and shallow
sand beds. For low yielding and freshly calved cows, cubicles
had deep sand bedding. As with farm 1, automatic scrapers
removed manure from pen passageways two or three times per
hour. Themilking parlour and the collecting yard were concreted
with no floor matting. Dry cows were kept on pasture during
summer months and housed in deep sanded cubicles in winter.
Youngstock were housed in concrete cubicles with straw.
On farm 3, animals were housed in deep sand bedded cubicles.
Pen passageways were scraped three times a day with a tractor.
The milking parlour and main race had floor matting. Dry cows
and youngstock were kept separately, each in its own unit. Dry
cows were housed in deep sand bedded cubicles.
All farms had foot trimming routines. In farms 1 and 3, all
animals were foot trimmed at drying off and around 60 days in
milk (DIM); whereas in farm 2, cows were only trimmed at drying
off. Footbathing was used in all farms. In farm 1, animals were
footbathed once a week with 3% formalin and twice a week with
4% copper sulphate as they exited the milking parlour. Farms 2
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and 3 only used 3% formalin in their footbaths. In farm 2, cows
were footbathed three times per week, and in farm 3, once a day.
Blood Samples
A blood sample was obtained from the coccygeal vein at three
time points-−30 days pre-calving, within 7 days from calving
and 30 days post-calving. Blood samples were collected into a
plain 5ml vacutainer (BD Vacutainer Serum Tube, BD, USA)
and allowed to clot at room temperature before being placed
on ice. Samples were transferred to the laboratory within a few
hours from collection where clotted blood was subsequently
centrifuged (Sigma 3–16kl, Sigma Laborzentrifugen, Germany)
at 2,500 rpm at 20◦C for 10min. Aliquots of serum were then
frozen at−20◦C.
Clinical Data Collection
Health data were recorded on the day blood samples were
collected by one of the two trained observers (GO and BG),
and mobility score (MS) and body condition score (BCS) were
recorded. The methods for collecting data on the mentioned
parameters are detailed by Griffiths et al. (19). Cows were
mobility scored when walking on a flat surface using the
four-point AHDB scale [0 = good mobility, 3 = severely
impaired mobility] (20). The BCS was assessed through the
Penn State Method [1 = very thin, 5 = obese] (21). For the
clinical observation of foot lesions, animals were restrained in a
trimming chute and their hoofs were lifted for assessment. Digital
dermatitis lesions were classified according to their stage using a
six-point scale (Table 1).
Additionally, the presence of other hoof health events was
assessed in all four hooves during the foot trimming performed at
60 days in milk and classified according to the ICAR Claw Health
Atlas (23) as per below:
• Bovine digital dermatitis
• Interdigital dermatitis
• Interdigital hyperplasia
TABLE 1 | Classification of digital dermatitis lesions according to macroscopic
aspect.
Stage Clinical descriptor
M1 Small (<2 cm across) focal active state. Circumscribed lesion. Surface
is moist, ragged, mottled red–grey with scattered small (∼1mm
diameter) red foci
M2 Larger (>2 cm across) ulcerative active stage. Extensively mottled
red–grey. Can be painful upon manipulation
M3 Healing stage. Typically seen within a few days after antibiotic
treatment. The ulcerated surface is now transformed to a dry brown,
firm rubbery scab. No pain on manipulation
M4 Chronic stage. Surface is raised by tan, brown, black, rubbery, irregular,
proliferative hyperkeratotic growths that vary from papilliform to
mass-like projections
M4.1 Chronic stage with small active painful M1 focus
M5 No sign of pre-existing lesion. Normal skin




• White line disease
• Other lesions
Laboratory Procedures
Preparation of Treponema Antigens
Treponema antigens were prepared as per Dhawi et al. (24) by
sonication of protein concentrate obtained from a culture of
Treponema Group 2 bacteria, previously isolated (Treponema
phagedenis T320A) from digital dermatitis lesions (25).
Indirect ELISA
Indirect ELISA tests were conducted on serum samples to assess
the presence of anti-Treponema antibodies (subclasses IgG1 and
IgG2). The protocol is outlined below but can be found in more
detail in the Supplementary Material alongside with the list of
reagents used.
Non-activated 96-well microtitre ELISA plates were coated
with sonicate protein extracts from T. phagedenis T320A
resuspended in PBS, pH 7.2; 5 µg protein/ml. The plates were
incubated for 1 h at 37◦C and overnight at 4◦C inside a lidded
humid sandwich box. The liquid in the wells was discarded and
the plates thoroughly washed three times with PBS-Tween 20
(0.05%) to remove unbounded antigen. Sera dilutes of cows were
prepared on the same day of the coating of the plates, at a
dilution of 1/1,000, by adding 10 µl of serum sample to 990 µl
of PBS-Tween 20 (0.05%) in an Eppendorf, and kept in the fridge
overnight at 4◦C.
After stirring the Eppendorf in the vortex stirrer, cow serum
samples (100 ul, 1:100 dilution in PBS-Tween 20) were pipetted
into the wells in duplicate. Diagram of the ELISA plate can be
found in the protocol in the Supplementary Material. Blank
control wells got 100 µl of PBS-Tween 20 (0.05%). Positive and
negative control serum samples were identified from a first set of
experiments and used throughout for comparison with test sera
to ensure data consistency.
The plates were incubated with sera samples for 1 h at
37◦C and plates were washed with PBS-Tween 20 (0.05%). One
hundredµl of mouse anti-bovine IgG (Bio-Rad; diluted 1:10,000)
were added to each well. The plates were again incubated at 37◦C
for 1 h.
The plates were washed as before, and 100 µl of peroxidase
conjugated goat anti-mouse IgG (Sigma), at a dilution of
1:10,000, was added to each well. The plates were incubated for
1 h at 37◦C.
After washing the plate, 100 µl of 3,3′,5,5′-
tetramethylbenzidine (Interchim) was added to each well
for detecting the antibody–conjugate reaction. The plates were
left for 20min in the dark at room temperature for 20min or
until the blue colour was saturated enough to prevent the loss
of linearity between the colour saturation and antibody titre.
After this period 100 µl of hydrochloric acid at 0.5M (Sigma)
were added to each well, and the results were read in a multi-well
ELISA plate reader (Multiskan, Titertek) at 405 nm. Each plate
was read three times and the average taken. The absorbance
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readings obtained from serum samples of animals known to
be negative for BDD signs (BDD-free farms) were used for
validating plates. These sample derived from another piece of
research (26). Plates were considered valid if the average from
the negative control duplicates were below the cut-off defined as
the mean of the results from the animal known to be negative
plus three standard deviations. The variation between duplicates
was calculated. All samples for which duplicates had a variation
over 20% were considered invalid, and samples were retested.
Data was normalized taking the positive control of each plate as
reference (27).
Data Management and Parameters
Microsoft Excel (2016) was used to collate the data and create the
data set (28). The health data collected with regards to BDD was
used to create new binary variables to explore their association
with the readings from the indirect ELISA as follows, with each
BDD lesion record assumed to be a case:
• Presence of BDD lesion(s) (yes/no)
• Presence of active DD lesions regardless of the number
(yes/no)—the definition of an active lesion followed the lesion
classification system and descriptors by Berry et al. (22), thus
M1, M2, and M4.1 lesions were classified as active
• Presence of active lesions considering the number (no
lesions/one lesion/more than one lesion)
Additionally, BCS was used to create a three-point scale variable
(29). The three-point scale BCS variable assumed the following
intervals—below 2.5, between 2.5 and 3.5 and above 3.5.
Moreover, animals were grouped according to their lactation into
three categories: first lactation, second lactation, third lactation,
or above. A binary variable for the ELISA test was also created
based on the absorbance readings for IgG1 and IgG2. The cut-off
value was defined by mean of the results from the animal known
to be negative plus three standard deviations.
Furthermore, animals were classified across five categories
according to lesion recording during the study period as
per below:
BDD health category Data collection time point
Pre-calving Around calving Post-calving
Healthy No lesion No lesion No lesion
Deteriorating No lesion No lesion Lesion(s)
No lesion Lesion(s) Lesion(s)
Recovering Lesion(s) No lesion No lesion
No lesion Lesion(s) No lesion
Lesion(s) Lesion(s) No lesion
Ever ill Lesion(s) Lesion(s) Lesion(s)
Other Lesion(s) No lesion Lesion(s)
Lastly, a categorical variable was created based on the disease
progression which considered three categories—no change,
improved, and worsen—by comparing lesion score in time t with
that at time t - 1. A shift from no lesion in time t - 1 to any other
score represented a worsening condition. An active lesion with
no signs of chronicity in time t - 1 could have an improvement
or a worsening of the health condition. If the animal had an
M1 lesion in time t - 1, its health condition could improve (no
lesion or M3 in time t) or deteriorate (M2, M4, and M4.1 in
time t). Similarly, if the animal had an M2 lesion in time t - 1,
it could improve (no lesion or M3 in time t) or get worse (M4
andM4.1 in time t). If anM4 lesion had been detected in t - 1, the
disease could progress (M4.1 in time t) or recede (no lesion or
M3 in time t). In case of a chronic lesion with signs of acuteness
(M4.1) lesion in t - 1, the health condition could only improve
(no lesion, M3 or M4 in time t). If the cow had the same lesions
score in consequent time periods, no change was assumed. The
correspondence of values across the different combinations can
be found in Supplementary Table 2.
Statistical Analysis
The analyses were conducted using RStudio statistical software
[version 1.3.1073] (30, 31).
Risk Factors for BDD Occurrence
A logistic regression model was developed using the package
finalfit (32). The explanatory variables—farm, data collection
time period, assessor, ELISA result for IgG1 result as a binary
variable, ELISA result for IgG2 as a binary variable, mobility
score, lameness, three-point scale body condition score, parity—
were individually assessed for their relation with the outcome
of interest—BDD presence. Those with a p-value equal or
lower than 0.1 were considered for the multivariable logistic
regression model. Animal identification number was used to
deal with within-subject repeated measurements as a random
effect. A backward elimination approach followed—explanatory
variables were eliminated one at the time, starting with the
one with the highest value, and the impact in the model’s
performance appreciated through the Akaike’s Information
Criteria (AIC), with lower values being rewarded. If the
model had a lower AIC, the variable was eliminated from the
model (33).
Association Between Absorbance and BDD Lesion
Score
The distribution of the absorbance readings for IgG1 and IgG2
was assessed for normality using the Shapiro–Wilk normality
test. Boxplots on the mean absorbance for IgG1 and IgG2
readings across the different BDD lesion scores were produced
using the package ggplot2 (34). The statistical significance of
the observed differences was assessed by the Kruskal–Wallis test
when more than two categories existed. If the p-value for the
Kruskal–Wallis test was lower than 0.05, the Dunn’s test for
multiple comparisons, with the “Holm” method to adjust for
the p-value, was conducted to assess the statistical significance
of the observed differences between the different groups (35).
The paired samples Wilcoxon test was used when only two
categories existed.
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Predictive Power of Indirect ELISA for Future
Occurrence of BDD Lesion
Acknowledging the usefulness of anticipating the future
occurrence of bovine digital dermatitis based on the current
readings of the indirect ELISA test, we assessed the correlation
between the ELISA test result in time t - 1 and the presence of
BDD lesion(s) in time t.
We fit two models, the first relating the transition probability
of each animal at time t to (a) the farm to which it belongs
and (b) positivity or not to antibody titre IgG1 at the previous
measurement at time t - 1; and the second relating the transition
probability of each animal at time t to (a) the farm to which
it belongs and (b) positivity to an antibody titre IgG2 at the
previous measurement at time t - 1. The response Yi is a binary
variable representing whether or not animal i has a lesion at time
t, conditional on them having no lesion and a positive ELISA test
at time t - 1, and takes the value 1 if the animal has a lesion at
time t and 0 if not. Times under consideration are t = 1 (30
days pre-calving), t = 2 (around calving), and t = 3 (30 days
post-calving). The model is fitted within the generalised linear
modelling framework thus:







= at + b1xi1t + b2xi2
where t again denotes visit (1, 2, or 3), xi1t the positivity of animal
i to the relevant antibody (IgG1 or IgG2) at visit (t - 1), and xi2
indicating the farm to which animal i belongs (one, two, or three,
included here as a fixed effect since these are the only farms of
interest to this study).
We also assessed whether the percentage variation in the
absorbance reading from t to t - 1 was associated with disease
evolution by comparing the mean percentage variation across the
different disease progression groups.
RESULTS
Data Exclusion
Out of the 773 available samples, only 696 were used in the
analysis, which resulted in 48 animals being excluded from
the analysis. Farm 3 had the most animals excluded from the
analysis−17 out of 48 (35%), whereas farm 2 was the one with
the least number of animals removed from the analysis−12
out of 48 (25%). Farm 1 had 13 (27%) animals excluded from
the analysis. Six animals (13%) were excluded as a result of
untraceable samples (Supplementary Table 3).
Samples were excluded for different reasons, and details can
be found in Supplementary Tables 4, 5. Missing samples were
the main cause for samples to be excluded from the analysis
accounting for 83% of the 77 dropped samples.
Descriptive Statistics
In total, 696 samples were processed corresponding to 232
animals, the majority of which (101) belonged to farm 1 (43.5%).
TABLE 2 | Distribution of sample population according to lactation number and
BDD progression type per farm.
Variable Category Farm 1 Farm 2 Farm 3
% N % N % N
Lactation number
1 32.7 33 24.0 12 27.2 22
2 22.8 23 20.0 10 37.0 30
3 or more 44.6 45 56.0 28 35.8 29
BDD progression
Healthy 59.4 60 36.0 18 51.8 42
Deteriorating 6.9 7 28.0 14 16.0 13
Recovering 15.8 16 16.0 8 18.5 15
Ever ill 11.8 12 16.0 8 12.3 10
Other 5.9 6 4.0 2 1.2 1
The least represented dairy unit was farm 2 with 50 animals
(21.6%). Farm 2 had more cows in their third or more lactation
when compared to the farm 1 and 3 (56.0% against 44.6 and
35.8%, respectively). Farm 2 had the highest proportion of cows
in the “deteriorating” (28%) and “ever ill” (16%) categories
compared to the other farms. More than half of the cows in farms
1 and 3 were classified as “healthy” according to BDD progression
(59.4 and 51.8%, respectively), whereas only 36% of the cows in
farm 2 were in the same category (Table 2).
Most of the data collection was conducted by one investigator
(BG) regardless of the farms and time point. Farm 1 had a lower
prevalence of lameness when compared to farms 2 and 3 across
all the time points. The most significant difference was at pre-
calving when 10.5% of the cows were lame in farm 1, whereas 29.2
and 27.8% had the same problem in farm 2 and 3, respectively.
Looking at body score condition (BSC) in a three-point scale, the
majority of cows (78% or more) were classified between 2.5 and
3.5 across all farm and time points. Farm 2 had 22% of cows with
a BSC over 3.5 at pre-calving, roughly 10%more when compared
to farm 1 and 3 (Table 3).
Considering the observation of clinical lesions throughout
the study, bovine digital dermatitis was more prevalent in
farm 2, particularly around and post-calving−42.0% and 48.0%
compared to 22.8 and 24.8% in farm 1 and 24.7 and 29.6%
in farm 3, respectively. Disease profile was different across the
different farms. Farm 1 had most of their cows with BDD
in the healing stage (M3) throughout the study period (63.3,
56.5, and 80.0% at pre-calving, around calving, and post-
calving, respectively). Farms 2 and 3 had 75% and 50% of
their affected animals with active lesions at pre-calving. As
the production cycle progressed, farm 2 revealed an increase
in M3 stage animals (52.4 and 54.2% for around and post-
calving, respectively) and a reduction of animals with M1
and M2 lesions (47.6 and 25.0% for around and post calving,
respectively). Farm 3 had the highest proportion of animals with
active lesions at around calving (55%) and post-calving (33.3%)
when compared to the other farms. It also had the highest
proportion of animals affected with BDD with signs of chronicity
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TABLE 3 | Summary statistics of categorical variables per data collection time point across farms.
Variable Category Farm 1 Farm 2 Farm 3
Pre C* AC* Post C* Pre C AC Post C Pre C AC Post C
% N % N % N % N % N % N % N % N % N
Assessor
BG 100.0 101 69.3 70 87.1 88 92.0 46 76.0 38 76.0 38 72.8 59 79.0 64 64.2 52
GO 0.0 - 30.7 31 12.9 13 8.0 4 24.0 12 24.0 12 27.2 22 21.0 17 35.8 29
3-Point scale BCS
<2.5 3.0 3 8.9 9 21.8 22 0.0 - 4.0 2 18.0 9 2.5 2 2.5 2 13.6 11
Between 2.5 and 3.5 84.2 85 87.1 88 78.2 79 78.0 39 92.0 46 82.0 41 85.2 69 88.9 72 86.4 70
>3.5 12.9 13 4.0 4 0.0 - 22.0 11 4.0 2 0.0 - 12.3 10 8.6 7 0.0 -
Mobility score
0 55.4 56 22.8 23 23.8 24 26.0 13 6.0 3 6.0 3 9.9 8 14.8 12 11.1 9
1 28.7 29 48.5 49 54.5 55 42.0 21 50.0 25 52.0 26 60.5 49 51.9 42 58.0 47
2 9.9 10 27.7 28 20.8 21 26.0 13 30.0 15 32.0 16 27.2 22 32.1 26 28.4 23
3 0.0 - 0.0 - 0.0 - 2.0 1 2.0 1 0.0 - 0.0 - 1.2 1 0.0 -
No data 5.9 6 1.0 1 1.0 1 4.0 2 12.0 6 10.0 5 2.5 2 0.0 - 2.5 2
Lameness
Normal 89.5 85 72.0 72 79.0 79 70.8 34 63.6 28 64.4 29 72.2 57 66.7 54 70.9 56
Lame 10.5 10 28.0 28 21.0 21 29.2 14 36.4 16 35.6 16 27.8 22 33.3 27 29.1 23
BDD lesion
No 70.3 71 77.2 78 75.2 76 68.0 34 58.0 29 52.0 26 74.1 60 75.3 61 70.4 57
Yes 29.7 30 22.8 23 24.8 25 32.0 16 42.0 21 48.0 24 25.9 21 24.7 20 29.6 24
BDD lesion score
M1 26.7 8 26.1 6 4.0 1 37.5 6 33.3 7 16.7 4 25.0 5 45.0 9 20.8 5
M2 3.3 1 0.0 - 0.0 - 37.5 6 14.3 3 8.3 2 25.0 5 10.0 2 12.5 3
M3 63.3 19 56.5 13 80.0 20 12.5 2 52.4 11 54.2 13 20.0 4 20.0 4 29.2 7
M4 6.7 2 13.0 3 16.0 4 6.3 1 0.0 - 16.7 4 20.0 4 15.0 3 29.2 7
M4.1 0.0 - 4.3 1 0.0 - 6.3 1 0.0 - 4.2 1 10.0 2 10.0 2 8.3 2
*Pre C, Pre-Calving; AC, Around calving; Post C, Post-Calving.
(M4 and M4.1 lesions) across all farms throughout the study
period−30.0, 25.0, and 37.5% at pre-, around, and post-calving,
respectively (Table 3).
Farm 2 and 3 had considerably higher records of claw
horn disruptive lesions at 60 days in milk (CHDL) when
compared with farm 1. Roughly half of the animals had at
least a lesion in farm 2 and 3 (48.0% and 50.6%, respectively);
whereas in farm 1, a CHDL was recorded 22.8% of the
times (Table 4).
Risk Factors for Bovine Digital Dermatitis
(Inferential Statistics)
In the univariate analysis farm, positiveness in the ELISA test for
both IgG1 and IgG2 antibodies, mobility score, lameness, and
parity were identified as risk factors (p ≤0.1) for the presence
of DD lesions, regardless of the affected hoof, and accepted for
the multivariate model. Animals in farm 2 had twice as much
the risk of having BDD when compared with farm 1 (OR 1.94,
95% CI 1.28–2.94), whereas cows from farm 3 were at the same
risk of having the disease as farm 1 (OR 1.01, 95% CI 0.69–1.49).
Animals testing positive in the ELISA for IgG1 or IgG2 antibodies
were at higher risk of having DD lesions when compared with
TABLE 4 | Distribution of claw horn disruptive lesions collected at 60 days in milk
across the three farms.
Variable Category Farm 1 Farm 2 Farm 3
% N % N % N
SUa
No 91.1 92 78.0 39 92.6 75
Yes 8.9 9 22.0 11 7.4 6
SHb
No 90.1 91 80.0 40 74.1 60
Yes 9.9 10 20.0 10 25.9 21
WLDc
No 92.1 93 76.0 38 67.9 55
Yes 7.9 8 24.0 12 32.1 26
CHDLd
No 77.2 78 52.0 26 49.4 40




dClaw Horn Disruption Lesion.
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those testing negative−4.06 the odds (95% CI 2.88–5.74) and
2.50 (95% CI 1.70–3.67) the odds, respectively. Lame animals had
1.49 times the odds (95% CI 1.03–2.15) of having DD lesions
when compared with non-lame animals. Additionally, animals
with mobility score (MS) one or two were at higher risk of having
BDD when compared to animals with MS = 0 (1.51 with a 95%
CI 0.97–2.40, and 2.06 OR with a 95% CI 1.26–3.42, respectively).
Animals in their second parity were at lower risk of having
BDD compared to animals in their first parity (0.66 OR, 95% CI
0.42–1.02; Table 5).
When running the multivariable logistic regression, the model
with parity group and ELISA result for IgG1 performed the
best when considering the AIC. Animals testing positive for
TABLE 6 | Odds ratio for the presence of DD lesions regardless of the affected
hoof in a multivariable logistic regression model.
Variable Categories Adjusted odds ratio (95% CI) p-value
IgG1 binary
Negative 1 (reference) -
Positive 4.34 (2.99–6.36) <0.001*
Parity group
1 1 (reference) -
2 0.65 (0.40–1.06) 0.085
3+ 0.56 (0.36–0.86) 0.008*
*Statistically significant when p < 0.05.
TABLE 5 | Risk factors for the presence of DD lesions regardless of the affected hoof in a univariate logistic regression model.
Variable Categories Bovine digital dermatitis Unadjusted odds ratio (95% CI, p-value)
No Lesions DD Lesions
% N % N
Farm
1 73.9 224 26.1 79 1 (reference)
2 59.3 89 40.7 61 1.94 (1.28–2.94, p = 0.002)*
3 73.7 179 26.3 64 1.01 (0.69–1.49, p = 0.944)
Data collection time point
Pre 71.1 165 28.9 67 1 (reference)
Fresh 72.4 168 27.6 64 0.94 (0.63–1.41, p = 0.757)
1 month 68.5 159 31.5 73 1.13 (0.76–1.68, p = 0.544)
Assessor
BG 70.1 390 29.9 166 1 (reference)
GO 72.9 102 27.1 38 0.88 (0.57–1.32, p = 0.559)
IgG1 binary
Negative 81.5 358 18.5 81 1 (reference)
Positive 52.1 134 47.9 123 4.06 (2.88–5.74, p < 0.001)*
IgG2 binary
Negative 74.8 416 25.2 140 1 (reference)
Positive 54.3 76 45.7 64 2.50 (1.70–3.67, p < 0.001)*
Body condition score−3 categories
<2.5 72.9 35 27.1 13 1 (reference)
Between 2.5 and 3.5 70.5 415 29.5 174 1.10 (0.58–2.08, p = 0.770)
>3.5 70.2 33 29.8 14 0.96 (0.64–1.40, p = 0.823)
Mobility score
0 78.8 119 21.2 32 1 (reference)
1 71.1 244 28.9 99 1.51 (0.97–2.40, p = 0.076)*
2 64.4 112 35.6 62 2.06 (1.26–3.42, p = 0.005)*
3 66.7 2 33.3 1 1.86 (0.08–20.01, p = 0.617)
Lameness
No 73.5 363 26.5 131 1 (reference)
Yes 64.4 114 35.6 63 1.53 (1.06–2.21, p = 0.016)*
Parity group
1 67.2 135 32.8 66 1 (reference)
2 75.7 143 24.3 46 0.66 (0.42–1.02, p = 0.065)*
3+ 69.9 214 30.1 92 0.88 (0.60–1.29, p = 0.510)
*Statistically significant when p < 0.05.
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FIGURE 1 | Mean absorbance reading for IgG1 anti-Treponema antibodies across the different DD lesion scores.
FIGURE 2 | Mean absorbance reading for IgG2 anti-Treponema antibodies across the different DD lesion scores.
IgG1 antibodies had approximately four times the odds of
having a DD lesion when compared to animals testing negative
(4.29 OR, 95% CI 2.97–6.28). Animals in their third or more
lactation had roughly half the odds of having a DD lesion when
compared with cows in their first lactation (0.56 OR, 95% CI
0.36–0.86; Table 6).
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Correlation Between ELISA Results and
BDD Lesions
The Shapiro–Wilk normality test indicated that the IgG1
and IgG2 absorbance readings were not normally distributed.
The Kruskal–Wallis test indicated that there were statistically
significant differences in the mean absorbance for IgG1 and IgG2
across the BDD lesions scores (p <0.01 for both IgG1 and IgG2;
Figures 1, 2). This was also observable across the different data
collection time points (Supplementary Figures 1, 2).
With the exception of animals with M4.1 lesions, the Dunn’s
test pairwise comparison revealed that the mean absorbance
reading for IgG1 and IgG2 anti-Treponema antibodies in animals
with no lesion was lower when compared to animals with BDD
lesions (p <0.05; Table 7). Looking at the data per time period,
the animals with no lesions had a lower mean absorbance reading
for IgG1 and IgG2 when compared to animals with M3 lesions at
around calving and post-calving (p <0.05). At pre-calving, the
mean absorbance reading for both IgG1 and IgG2 was found to
be significantly different between animals with no lesions and
animals with M2 lesions (p < 0.05; Table 7).
Looking at the relationship between mean absorbance
readings for IgG1 and IgG2 anti-Treponema antibodies and the
presence of an active BDD lesion(s), the Kruskal–Wallis test also
showed that the observed differences were significant (p < 0.01
for both cases; Figures 3, 4). Apart from the mean absorbance
reading for IgG2 at post-calving, the pairwise comparison using
Dunn’s test indicated that the mean absorbance reading for
IgG1 and IgG2 in animals with no lesions was significantly
lower than animals with one active lesions (p < 0.05). When
comparing the mean absorbance reading for IgG1 and IgG2
between the group of animals with no active lesions and
the group of animals with more than one active lesions, the
later had a higher value considering all data point (p <
0.05). This was also observable for IgG1 at pre- and post-
calving and for IgG2 at pre-calving (p < 0.05; Table 8 and
Supplementary Figures 3, 4).
Correlation Between Anti-Treponema
Antibodies and BDD Health Category
When looking at the mean absorbance reading for IgG1
and IgG2 anti-Treponema antibodies across the different BDD
health categories, the Kruskal–Wallis test indicated significant
differences between groups when considering all the data and
when looking across the different data collection time points (p
< 0.05; Supplementary Figures 5–8).
The Dunn’s test for pairwise comparison revealed that the
group of animals labelled as healthy had lower mean absorbance
reading for both IgG1 and IgG2 when compared to the group
of animals classified as deteriorating and ever ill, regardless of
TABLE 8 | Pairwise comparison of mean absorbance readings across different
categories regarding number of active BDD lesions.








vs. two or more
active lesions
IgG1 0.000* 0.000* 0.413
IgG1-t1a 0.000* 0.013* 0.607
IgG1-t2b 0.001* 0.607 0.622
IgG1-t3c 0.028* 0.023* 0.218
IgG2 0.000* 0.036* 0.931
IgG2-t1 0.000* 0.006* 0.349
IgG2-t2 0.005* 0.846 0.292





*Significant p-values (<0.05) in bold.
TABLE 7 | Pairwise comparison of mean absorbance readings across different BDD lesion scores.































IgG1 0.000* 0.000* 0.000* 0.000* 0.155 0.082 1.000 1.000 1.000 0.138 1.000 1.000 1.000 0.790 1.000
IgG1-t1a 0.1064 0.000* 0.674 0.146 1.000 0.570 1.000 1.000 0.919 0.075 1.000 1.000 1.000 1.000 1.000
IgG1-t2b 0.107 0.368 0.000* 0.473 1.000 1.000 1.000 1.000 0.961 1.000 1.000 1.000 1.000 1.000 1.000
IgG1-t3c 0.481 0.059 0.001* 0.017* 0.323 1.000 1.000 1.000 1.000 1.000 1.000 0.998 1.000 1.000 1.000
IgG2 0.005* 0.000* 0.000* 0.005* 0.226 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.982 1.000 1.000
IgG2-t1 0.246 0.001* 1.000 0.110 1.000 0.707 1.000 1.000 1.000 0.051 1.000 1.000 0.647 1.000 0.859
IgG2-t2 0.506 1.000 0.000* 1.000 1.000 0.969 0.554 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000





*Significant p-values (<0.05) in bold.
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FIGURE 3 | Mean absorbance reading for IgG1 anti-Treponema antibodies according to the presence of active DD lesion.
FIGURE 4 | Mean absorbance reading for IgG2 anti-Treponema antibodies according to the presence of active DD lesion.
whether all data was considered, or when looking at the data per
time period (p < 0.05). This was also evident when comparing
the group recovering with the ever ill group—apart from the
absorbance reading for IgG1 at pre calving, the later had higher
mean absorbance readings for both IgG1 and IgG2 (p < 0.05).
The ever ill group had higher mean absorbance reading for IgG1
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TABLE 9 | Pairwise comparison of mean absorbance readings across different BDD health categories.































IgG1 0.001* 0.000* 0.000* 0.106 0.093 0.000* 0.911 0.014* 0.380 0.007*
IgG1-1a 0.187 0.005* 0.000* 0.653 0.802 0.052 1.000 0.546 0.759 0.699
IgG1-t2b 0.117 0.006* 0.000* 1.000 1.000 0.009* 0.793 0.112 0.804 0.118
IgG1-t3c 0.274 0.000* 0.000* 0.564 0.341 0.013* 0.993 0.717 0.773 0.317
IgG2 0.100 0.000* 0.000* 0.129 0.020* 0.000* 0.438 0.008* 0.608 0.009*
IgG2-t1 1.000 0.013* 0.000* 0.985 0.406 0.001* 0.721 0.240 0.920 0.262
IgG2-t2 0.512 0.008* 0.000* 1.000 0.580 0.002* 0.964 0.141 0.771 0.132






*Significant p-values (<0.05) in bold.
and IgG2 reading when compared to any of the other health
categories (p < 0.05; Table 9).
Predictive Power of ELISA Test in Future
Occurrence of BDD Lesion(s)
The results from the generalised linear model-based transition
models showed limited predictive power of the ELISA test upon
the future occurrence of BDD lesions for both IgG1 and IgG2
anti-Treponema antibodies. Farm 2 had higher occurrence of
BDD lesions. When looking at the absorbance readings for IgG1,
animals from farm 2 were at higher risk of developing BDD
lesions around calving compared to farm 1 (4.03 OR, p = 0.02).
When considering the absorbance readings for IgG2, farm 2
animals were at higher risk of developing lesions both at around
calving and 1month post-calving when compared to farm 1 (4.16
OR, p= 0.016 and 3.42 OR, p= 0.023, respectively; Table 10).
The mean variation in the absorbance readings from t to t
- 1 for both IgG1 and IgG2 was not associated with disease
progression, neither when considering all data, nor when looking
at the data per time period (p-value for Kruskal–Wallis > 0.05;
Supplementary Figures 9–12).
DISCUSSION
This paper explored the usefulness of measuring anti-Treponema
antibody titres through indirect ELISA test in the identification
of cows at different stages of BDD, and prediction power of this
diagnostic tool in the future occurrence of disease.
The results indicated that the absorbance readings from
indirect ELISA were significantly associated with BDD profile.
With the exception of M4.1 score, animals with no lesions had
in general lower mean absorbance readings when compared with
the other lesion scores for both IgG1 and IgG2 anti-Treponema
antibodies. Additionally, the mean absorbance reading in the
TABLE 10 | Results from the generalised linear models assessing the predictive
power of ELISA test in the future occurrence of BDD lesion(s).
Model OR (95% CI) p-value
IgG1
Predicting occurrence of IgG1 at Negative 1 (reference) -
BDD around calving pre-calving Positive 0.91 (0.32-2.40) 0.8467
Farm Farm 1 1 (reference) -
Farm 2 4.03 (1.25–13.81) 0.0207
Farm 3 1.67 (0.55–5.36) 0.3690
Predicting occurrence of IgG1 around Negative 1 (reference) -
BDD post-calving calving Positive 1.01 (0.34–2.70) 0.9858
Farm Farm 1 1 (reference) -
Farm 2 2.73 (0.92–8.04) 0.0664
Farm 3 1.34 (0.53–3.37) 0.5314
IgG2
Predicting occurrence of IgG2 at Negative 1 (reference) -
BDD around calving pre-calving Positive 0.73 (0.19–2.33) 0.6242
Farm Farm 1 1 (reference) -
Farm 2 4.16 (1.32–13.99) 0.0161
Farm 3 1.65 (0.54–5.29) 0.3822
Predicting occurrence of IgG2 around Negative 1 (reference) -
BDD post-calving calving Positive 0.37 (0.08–1.26) 0.1502
Farm Farm 1 1 (reference) -
Farm 2 3.42 (1.17–10.03) 0.0231
Farm 3 1.37 (0.54–3.47) 0.4987
Significant p-values (<0.05) in bold.
group of cows with no lesions for both IgG1 and IgG2 anti-
Treponema antibodies was significantly lower when compared to
the group of animals with one active lesion and with two or more
active lesions. Furthermore, BDD health category was associated
with mean absorbance reading. The groups of animal diagnosed
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with a BDD lesion in all three time point assessments (ever
ill) had significantly higher absorbance mean when compared
to any of the other BDD health groups for both IgG1 and
IgG2 anti-Treponema antibodies. Also the deteriorating group
had significant higher absorbance mean when compared to the
group of animals that had no BDD lesions throughout the
study period. Despite the chronic exposure to Treponema spp.
due to the endemic nature of BDD, these findings suggest that
different disease stages lead to different immunologic profiles
that can be measured through indirect ELISA allowing for
the identification of BDD status in dairy cows. A previous
study looked at the immunologic profile across different BDD
lesion scores and found that M2 lesions resulted in higher
titres compared with other lesions (18). Although no significant
differences were observed in the mean readings between the
different BDD lesion scores, the p-value for some of the pairwise
comparisons was close to the significance level (0.05). In a
recent study, Holmøy et al. (36) found that ELISA tests could
identify anti-Treponema antigens in milk samples from the
bulk tank. Unfortunately, the diagnostic test did not perform
well with regards to sensitivity and specificity, probably due
to the disease prevalence (low) and profile (mild symptoms)
in the study population (36). Similarly, a weakness of our
analysis is that the samples are non-random and originate from
three farms only: as such milder cases (lower scores) are more
heavily represented than more severe cases (higher scores) in
the data set and this may have impacted upon the power of
the analysis to detect associations between dependent variables
and lesion score. Evaluating the effectiveness of a diagnostic
tool such as indirect ELISA in the identification of disease
profile at the herd level in a larger (ideally random) sample,
which more comprehensively represents the profile of lesion
scores across all levels of severity, could result in an objective
alternative to the current reference method—visual inspection of
lifted hooves.
Farm as a unit was identified as a risk factor for BDD with
animals in farm 2 having double the odds of BDD lesions when
compared to farm 1. This is reinforced by the findings from
the transition model in which farm 2 was a predictor for the
future occurrence of BDD lesions. The role of farm management
practices has been acknowledged in BDD incidence (37, 38).
Foot trimming has also been identified as a measure to reduce
BDD incidence (39, 40). Somers et al., reported that animals
trimmed at longer intervals (>7 months) were at a higher risk
of developing the disease when compared to animals trimmed
more frequently (41). As opposed to farms 1 and 3, cows in
farm 2 were only trimmed once a year at drying-off. Between
farm differences in hygiene levels and in foot bathing practices
could also explain these findings. Even though an in-depth
investigation would be required to reach valid conclusion as to
the observed differences, the distinct farm management practices
and hoof health prevention protocol between farms could offer
an explanation to the observed dissimilarities.
Literature has indicated that cow-level risk factors impact
on BDD occurrence such as parity number, with primiparous
cows at higher risk when compared to multiparous (42).
This is in line with the results from multivariate model in
which cows with three or more lactation were at lower risk
of BDD when compared with cows in their first lactation.
Different reasons could explain such observation. It may
relate to selection of older cows with lesions for culling
leading to a reduction of disease prevalence with age (43).
Alternatively, the early culling of dairy heifers affected with BDD
could promote a selection of animals less susceptible to the
disease (5).
Although a correlation between the readings from the
indirect ELISA and the different BDD disease presentations was
established, the usefulness of the laboratory test in identifying
diseased animals as a binary outcome is questionable, as it
failed to consistently classify animals with clinical manifestations
of disease as positive—out of the 696 test results, 81 were
false negatives when testing for the presence of IgG1 and
140 were false negatives when assessing the presence of IgG2.
Additionally, the lab test failed to predict in a reliable manner
the future occurrence of BDD lesions, limiting its usefulness in
the implementation of pre-emptive measures to control disease
onset. It must be noted that the endemic nature of BDD means
that animals are chronically exposed to Treponema spp. and
hence antibody levels do not necessarily reflect current infection
status (16).
The small sample of farms enrolled in the study might have
limited our ability to reach significant results. Given the role
of farm management in disease incidence and presentation, it
would be interesting to further explore the potential usefulness
of indirect ELISA in a larger sample of farms. Additionally,
the very low incidence of certain disease stages, particularly the
M4.1 stage, might have limited the capacity to find significant
differences regarding absorbance readings across the different
disease stages. The results that were reached make room for
further investigating association between indirect ELISA results
and disease stages, and the magnitude of the differences, ideally
with a larger dataset.
The implications of disease diagnostic are not just limited
to the clinical aspects of animal health management by making
sure that adequate and successful treatment and control protocols
are adopted. It is also a key aspect regarding the overall
picture of disease patterns and associated economic impact—
a vital information for the decision-making process regarding
the management of animal diseases at farm and higher levels
of governance (44, 45). In the absence of such information,
it is not possible to determine if allocation of the resources
is efficient from an economic or welfare perspective. Having
diagnostic methods and tools that, for their subjective nature,
underestimate the frequency of disease could impair our ability
to properly acknowledge the importance of diseases in the overall
scenario of production losses and expenditure related to a given
sector of animal production. As such objective methods for
identifying animals with impaired productivity and/or welfare
with subsequent investigation of the underlying causes are
important for informing the clinical management of diseases and
the assessment of animal disease impacts.
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